Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
eisai
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
biotech
fda
alzheimer's disease
bristol-myers squibb
cancer
galapagos nv
nonalcoholic steatohepatitis
obamacare
pfizer
purdue pharma
sarepta therapeutics
What
bio
drug
roundup
week
alzheimer’s
biogen
aducanumab
america
amyloid
angst
annual
assessed
attention
bagged
billions
biogen’s
biotech
brammer
cancer
communities
conference
continues
convoluted
democrats
dreams
effects
eisai
esmo
europe
failure
fda
felt
flags
germany
head
headaches
healthcare
higher
holding
hosted
Language
unset
Current search:
eisai
×
photo
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
